What is DOTS Technology?
DOTS Technology is at the forefront of transforming the diagnostics field by enabling point-of-care detection. The company's initial product is designed to identify the presence of food allergens, addressing a critical need in food safety and consumer health. By shifting detection capabilities to the point of care, DOTS aims to provide faster, more accessible, and reliable diagnostic results, moving away from traditional laboratory-based testing.
How much funding has DOTS Technology raised?
DOTS Technology has raised a total of $29.3M across 3 funding rounds:
Series A
$8M
Series B
$20.9M
Debt
$350K
Series A (2015): $8M, investors not publicly disclosed
Series B (2017): $20.9M, investors not publicly disclosed
Debt (2020): $350K supported by PPP
Key Investors in DOTS Technology
PPP
Public-Private Partnership
What's next for DOTS Technology?
With the recent injection of major strategic capital, DOTS Technology is poised for significant expansion. The enterprise-level backing suggests a focus on scaling operations, further product development, and potentially broader market penetration. This investment will likely enable the company to enhance its diagnostic platform, expand its allergen detection capabilities, and explore new applications within the diagnostics sector. The company's trajectory indicates a strong commitment to innovation and market leadership in the rapidly evolving field of diagnostics.
See full DOTS Technology company page
